HOME >> BIOLOGY >> NEWS
Genetic therapy reverses nervous system damage in animal model of inherited human disease

PHILADELPHIA By injecting a therapeutic gene directly into the brain, researchers have treated a naturally occurring genetic disease in cats. This is the first genetic disease affecting the central nervous system to be successfully treated in an animal larger than mice and rats. If this approach can be successfully applied to humans, say the researchers, it might one day treat an entire class of diseases called lysosomal storage disorders which cause severe, sometimes fatal, disabilities in about one in 5,000 births. The members of the research team from the University of Pennsylvania School of Veterinary Medicine, the Children's Hospital of Philadelphia and the U.S. Naval Academy published their findings in this month's issue of the Annals of Neurology

The animals involved in the study are born with a genetic disorder directly analogous to alpha-mannosidosis or AMD, an inherited disease in humans that causes severe mental retardation and skeletal abnormalities. Cats with AMD do not live more than six months. Children born with the worst form of the disease rarely survive into their teens.

"Through gene therapy, we replace a 'broken' gene responsible for alpha-mannosidase with the correct, functioning copy, to dramatic results," said John H. Wolfe, a professor of pathology and medical genetics at the Penn School of Veterinary Medicine and a neurology researcher at Children's Hospital. "The treated cats were markedly improved compared to diseased cats, with better balance and muscle control and fewer tremors."

Although the disease itself is rare, AMD is one of about 50 lysosomal storage diseases, a class of diseases that accounts for a significant portion of the instances of mental retardation in children. Other examples include Tay-Sachs disease, Hunter disease and Pompe disease. In a lysosomal storage disease, cellular debris accumulates within storage areas of cells called lysosomes. In the case of AMD, children are born with a faul
'"/>

Contact: Greg Lester
glester@pobox.upenn.edu
215-573-6604
University of Pennsylvania
9-Mar-2005


Page: 1 2 3

Related biology news :

1. Genetic variation helps to understand predisposition to schizophrenia
2. Genetic factors strongly shape how peers are chosen
3. Genetic analysis finds greater threat in frog-killing fungus
4. Genetic diversity in honeybee colonies boosts productivity
5. 2007-2008 Genzyme/ACMGF Clinical Genetics Fellowship In Biochemical Genetics award winner announced
6. Maynard Olson receives $500,000 Gruber Genetics Prize
7. Genetic defect links respiratory disease and congenital heart disease
8. Cell Press announces new partnership with the American Society of Human Genetics
9. Genetic fellow traveler discovered in Alzheimers
10. Genetic roots of bipolar disorder revealed by first genome-wide study of illness
11. Health disparities -- Genetics, society and race play an important role in access to healthcare

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/26/2020)... ... April 23, 2020 , ... SECO , ... FII Tech Growth managed by Fondo Italiano d’Investimento SGR, today announced a partnership ... development of Respira, a new non-invasive pulmonary ventilator created in response to the ...
(Date:4/22/2020)... ... April 21, 2020 , ... ... and innovation in technology and compliance, announces a new managed service to improve ... of alliances – Box, ComplianceQuest, and USDM Life Sciences (USDM) – Unify Compliance ...
(Date:4/16/2020)... ... April 15, 2020 , ... RoosterBio Inc., a leading supplier ... announces that the Medical Technology Enterprise Consortium (MTEC) recognized a multi-institution team with ... March. The Regenerative Medicine (RegenMed) biomanufacturing collaboration had created a team initiative led ...
Breaking Biology News(10 mins):
(Date:5/21/2020)... ... May 21, 2020 , ... Threats to intellectual property, ... , Contrary to conventional wisdom that says the coronavirus pandemic will generally benefit ... emerge from the pandemic commercially weaker, dealing with delays in new product launches ...
(Date:5/21/2020)... ... ... Eaton Square is pleased to announce its growth on the East Coast of ... strategy and M&A advisory firm. , This is an important step for Eaton Square ... healthcare innovators with capital and investors. , Popper and Company, founded in 2003 by ...
(Date:5/15/2020)... , ... May 14, 2020 ... ... of human mesenchymal stem/stromal cell (hMSC) working cell banks and hMSC bioprocess ... enable streamlined and multi-format collection of hMSC-derived extracellular vesicles (EVs). RoosterCollect™-EV-CC is ...
(Date:5/15/2020)... ... 2020 , ... This new service offers clients a way to speak with ... as the need arises. Lachman’s OnCall SMEs have extensive knowledge of a wide range ... Lachman OnCall™ SMEs are available normal business hours Monday through Friday from 9:00 am ...
Breaking Biology Technology:
Cached News: